Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Aimmune Therapeutics, Inc. (AIMT)
Sector: Healthcare; Industry: Biotechnology

Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies. Aimmune Therapeutics, Inc. has a strategic collaboration with an affiliate of Nestle Health Science US Holdings, Inc. for the advancement of food allergy therapeutics; and clinical collaboration agreement with Regeneron Ireland Unlimited Company and Sanofi Biotechnology SAS to study AR101 with adjunctive dupilumab in peanut-allergic patients in a Phase II trial. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. in May 2015.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2018-11-19 Barrowcliffe Susan E. General Manager, Europe Sell 40,000 $30.04 $1,201,600 Yes
2018-01-02 Barrowcliffe Susan E. General Manager, Europe Sell 75,000 $37.14 $2,785,190 Yes
2017-09-25 Barrowcliffe Susan E. General Manager, Europe Sell 20,000 $25.00 $500,000 Yes
2017-09-06 Barrowcliffe Susan E. General Manager, Europe Sell 18,390 $22.00 $404,615 Yes
2017-07-27 Barrowcliffe Susan E. General Manager, Europe Sell 500 $22.00 $11,000 Yes
2017-07-25 Barrowcliffe Susan E. General Manager, Europe Sell 6,110 $22.00 $134,420 Yes
2017-07-03 Barrowcliffe Susan E. General Manager, Europe Sell 15,000 $20.26 $303,910 Yes
2016-11-11 Barrowcliffe Susan E. General Manager, Europe Sell 20,000 $25.00 $500,000 Yes
2016-11-08 Barrowcliffe Susan E. General Manager, Europe Sell 15,000 $20.00 $300,000 Yes

Insider Smart

Mohawk Group Holdings, Inc. (MWK) - Multiple insiders bought MWK in June around $5, stock moved sideways for a month then made a 60% jump in 10 days. Patience is the key.